Navigation Links
ThromboGenics Announces 2007 Full Year Results
Date:3/13/2008

F, such as TB-403, can selectively inhibit tumor growth by blocking its blood supply without affecting normal tissues. TB-403 is now in Phase I development.

- ThromboGenics may enter into partnerships or license agreements to commercialize its products and this preferably after Phase II.

Financial Summary

- In 2007, revenue amounted to EUR1.5m, mainly coming from out-licensing. Operating expenses were EUR20.0m in 2007, the majority of which were due to R&D expenses related to our increasing number of clinical development programs. The net loss for the year was EUR16.0m.

- As of 31 December 2007, ThromboGenics had EUR46.1m in cash and cash equivalents. This compared to EUR32.04m on 31 December, 2006, and results from the fundraising that the Company completed in May 2007.

- The Group streamlined its organization with the absorption of the fully owned subsidiary Thromb-X.

Prof Desire Collen, CEO of ThromboGenics, commenting on today's announcement, said: "I am very pleased with what we have achieved during the course of 2007, particularly the successful fund raising we completed in May, which broadened our shareholder base. The additional funds raised will allow us to advance our exciting clinical development portfolio, which is progressing as planned. I am also very happy with the encouraging results that we have obtained with microplasmin in clinical trials targeting "back of the eye" diseases. These results further strengthen our belief that this product will be of great value to the ophthalmic community. In addition, we have made good progress with our earlier programs, including anti-PlGF (TB-403), where our Cell paper generated significant interest in this exciting new approach for cancer therapy, and which progressed to Phase I."

The full financial results statement can be found at http://www.thrombogenics.com

About ThromboGenics

ThromboGenics
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
2. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
3. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
4. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
5. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
6. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
7. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
8. EntreMed Announces 2008 Corporate and Clinical Program Priorities
9. Arpida Announces Full Year 2007 Financial Results
10. Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
11. WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
(Date:7/24/2014)... July 24, 2014  Spherix Incorporated (SPEX) -- an ... monetization of intellectual property, today announced that the Company ... June 30, 2014 on Monday, August 18, 2014 for ... a.m. ET on Monday, August 18, 2014 to discuss ... the company,s CEO, Anthony Hayes . ...
(Date:7/23/2014)... Khaimah, United Arab Emirates (UAE) (PRWEB) July 23, 2014 ... Grace Century recently announced that its biobanking ... Jim Vaught , Ph.D. to its growing Advisory Board. ... “We are very pleased to have Dr. Vaught onboard ... the scientific depth and expertise that Provia’s management team ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- Think Drinks are a neuroscience-backed ... long term. They are the first functional focus beverage ... as an alternative to the temporary fix associated with ... on July 29, 2014, with hopes to raise $50,000 ... Photo - http://photos.prnewswire.com/prnh/20140723/129697 Think ...
Breaking Biology Technology:Neogen comments on SenesTech 2Spherix Schedules Shareholder Update Call 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2
... senior executives from companies and government organizations will gather ... produced by ... In the foreseeable future a,trip to the doctor,s office ... Armed with our complete genetic profile information about,predisposition to disease, ...
... Southern Research,Institute today announced that it has ... to Virium Pharmaceuticals, Inc. To date, six of,Southern ... are on,the market. Six others, including 4,-Thio-Ara-C, are ... trials. (Photo: http://www.newscom.com/cgi-bin/prnh/20070913/DCTH022 ) ...
... BASINGSTOKE, England, September 13 In order,to meet its ... Shire plc ("Shire") (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ... ended 30 June 2007,in accordance with International Financial Reporting ... 26 July 2007, Shire announced its results in,respect of ...
Cached Biology Technology:The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco 2Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals 2IFRS Information - First Half of 2007 2IFRS Information - First Half of 2007 3IFRS Information - First Half of 2007 4IFRS Information - First Half of 2007 5IFRS Information - First Half of 2007 6IFRS Information - First Half of 2007 7IFRS Information - First Half of 2007 8IFRS Information - First Half of 2007 9IFRS Information - First Half of 2007 10IFRS Information - First Half of 2007 11IFRS Information - First Half of 2007 12IFRS Information - First Half of 2007 13IFRS Information - First Half of 2007 14IFRS Information - First Half of 2007 15IFRS Information - First Half of 2007 16IFRS Information - First Half of 2007 17IFRS Information - First Half of 2007 18IFRS Information - First Half of 2007 19IFRS Information - First Half of 2007 20IFRS Information - First Half of 2007 21IFRS Information - First Half of 2007 22IFRS Information - First Half of 2007 23IFRS Information - First Half of 2007 24IFRS Information - First Half of 2007 25IFRS Information - First Half of 2007 26IFRS Information - First Half of 2007 27IFRS Information - First Half of 2007 28IFRS Information - First Half of 2007 29IFRS Information - First Half of 2007 30IFRS Information - First Half of 2007 31IFRS Information - First Half of 2007 32IFRS Information - First Half of 2007 33
(Date:7/23/2014)... of Antarctic fur seals, alongside decades of in-depth ... of climate change on a population of top-predators. ... findings show that the seals have significantly altered ... are associated with climate conditions. Despite a shift ... is not passing down through generations, leaving the ...
(Date:7/23/2014)... Spinach gave Popeye super strength, but it also ... group of scientists: the ability to convert sunlight into ... are part of an international group using spinach to ... which plants convert the sun,s energy into carbohydrates used ... are part of the most efficient system ever built, ...
(Date:7/23/2014)... July 23, 2014 Migratory songbirds are disappearing, and ... climate change, loss of habitat, acid rain and light ... missing: where do these birds go once they leave ... encountering along the way? , To answer this question, ... created the first ever migratory connectivity map produced for ...
Breaking Biology News(10 mins):Genetic study shows major impact of climate change on Antarctic fur seals 2Genetic study shows major impact of climate change on Antarctic fur seals 3Spinach could lead to alternative energy more powerful than Popeye 2York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2
... on epigenetics (the inheritance of propensities acquired in the ... and other foodsduring pregnancy may significantly affect breast cancer ... team of biologists at Boston University is the first ... It also is the first to identify possible choline-related ...
... the common chest wall deformity known as pectus excavatum ... according to a study published December in the journal ... North American hospitals, involved telephone interviews of more than ... who had pectus excavatum surgery. Researchers interviewed parents ...
... December 2008 issue of BioScience includes a Special ... Environment, coordinated by Louis J. Guillette, Jr., of the University ... the issue is as follows: Meeting the Challenges ... P. Incardona, and Matthew L. Rise. , As a model ...
Cached Biology News:Eating eggs when pregnant affects breast cancer in offspring 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 3BioScience tip sheet, December 2008 2
... is a compact benchtop and stackable ... controller with a large display screen ... speed. Air circulation inside to evenly ... can be easily calibrated from the ...
... compact benchtop and stackable multi-function incubator. ... a large display screen to accurately ... circulation inside to evenly distribute temperature ... easily calibrated from the microprocessor controller. ...
... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...
... is a compact benchtop and stackable ... controller with a large display screen ... speed. Air circulation inside to evenly ... can be easily calibrated from the ...
Biology Products: